WEST PHARMACEUTICAL SERVICES, INC. Gain (Loss) on Fair Value Hedges Recognized in Earnings
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Gain (Loss) on Fair Value Hedges Recognized in Earnings of -$300.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. gain (loss) on fair value hedges recognized in earnings for the quarter ending 2026-06-30 was -$300.00K, a 160.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. gain (loss) on fair value hedges recognized in earnings for the quarter ending 2026-03-31 was $1.20M, a 200.00% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. gain (loss) on fair value hedges recognized in earnings for the quarter ending 2025-12-31 was $200.00K, a 66.67% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. gain (loss) on fair value hedges recognized in earnings for the quarter ending 2025-09-30 was $400.00K, a 77.78% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. gain (loss) on fair value hedges recognized in earnings for fiscal 2025 was $1.50M, a 74.58% decline from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. gain (loss) on fair value hedges recognized in earnings for fiscal 2024 was $5.90M, a 321.43% increase from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. gain (loss) on fair value hedges recognized in earnings for fiscal 2023 was $1.40M.
- WEST PHARMACEUTICAL SERVICES, INC. gain (loss) on fair value hedges recognized in earnings for fiscal 2022 was -$5.20M.
| Period end | Gain (Loss) on Fair Value Hedges Recognized in Earnings 3 month | Gain (Loss) on Fair Value Hedges Recognized in Earnings 3 month as first filed | Gain (Loss) on Fair Value Hedges Recognized in Earnings 6 month | Gain (Loss) on Fair Value Hedges Recognized in Earnings 6 month as first filed | Gain (Loss) on Fair Value Hedges Recognized in Earnings 9 month | Gain (Loss) on Fair Value Hedges Recognized in Earnings 9 month as first filed | Gain (Loss) on Fair Value Hedges Recognized in Earnings 12 month | Gain (Loss) on Fair Value Hedges Recognized in Earnings 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$300.00K 10-Q · filed 2026-07-23 | $900.00K 10-Q · filed 2026-07-23 | $1.10M derived: sum of 3 quarters · filed 2026-07-23 | $1.50M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2026-03-31 | $1.20M 10-Q · filed 2026-04-23 | $1.40M derived: sum of 2 quarters · filed 2026-04-23 | $1.80M derived: sum of 3 quarters · filed 2026-04-23 | $2.30M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $600.00K derived: sum of 2 quarters · filed 2026-02-17 | $1.10M derived: sum of 3 quarters · filed 2026-07-23 | $1.50M 10-K · filed 2026-02-17 | ||||
| 2025-09-30 | $400.00K 10-Q · filed 2025-10-23 | $900.00K derived: sum of 2 quarters · filed 2026-07-23 | $1.30M 10-Q · filed 2025-10-23 | $1.90M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-06-30 | $500.00K 10-Q · filed 2026-07-23 | $900.00K 10-Q · filed 2026-07-23 | $1.50M derived: sum of 3 quarters · filed 2026-07-23 | $3.30M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-03-31 | $400.00K 10-Q · filed 2026-04-23 | $1.00M derived: sum of 2 quarters · filed 2026-04-23 | $2.80M derived: sum of 3 quarters · filed 2026-04-23 | $4.50M derived: sum of 4 quarters · filed 2026-04-23 | ||||
| 2024-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.40M derived: sum of 2 quarters · filed 2026-02-17 | $4.10M derived: sum of 3 quarters · filed 2026-02-17 | $5.90M 10-K · filed 2026-02-17 | ||||
| 2024-09-30 | $1.80M 10-Q · filed 2025-10-23 | $3.50M derived: sum of 2 quarters · filed 2025-10-23 | $5.30M 10-Q · filed 2025-10-23 | $5.00M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-06-30 | $1.70M 10-Q · filed 2025-07-24 | $3.50M 10-Q · filed 2025-07-24 | $3.20M derived: sum of 3 quarters · filed 2026-02-17 | $5.20M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-03-31 | $1.80M 10-Q · filed 2025-04-24 | $1.50M derived: sum of 2 quarters · filed 2026-02-17 | $3.50M derived: sum of 3 quarters · filed 2026-02-17 | $4.40M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2023-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.70M derived: sum of 2 quarters · filed 2026-02-17 | $2.60M derived: sum of 3 quarters · filed 2026-02-17 | $1.40M 10-K · filed 2026-02-17 | ||||
| 2023-09-30 | $2.00M 10-Q · filed 2024-10-24 | $2.90M derived: sum of 2 quarters · filed 2024-10-24 | $1.70M 10-Q · filed 2024-10-24 | $900.00K derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-06-30 | $900.00K 10-Q · filed 2024-07-25 | -$300.00K 10-Q · filed 2024-07-25 | -$1.10M derived: sum of 3 quarters · filed 2025-02-18 | -$3.30M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-03-31 | -$1.20M 10-Q · filed 2024-04-25 | -$2.00M derived: sum of 2 quarters · filed 2025-02-18 | -$4.20M derived: sum of 3 quarters · filed 2025-02-18 | -$5.60M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2022-12-31 | -$800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$3.00M derived: sum of 2 quarters · filed 2025-02-18 | -$4.40M derived: sum of 3 quarters · filed 2025-02-18 | -$5.20M 10-K · filed 2025-02-18 | ||||
| 2022-09-30 | -$2.20M 10-Q · filed 2023-10-26 | -$3.60M derived: sum of 2 quarters · filed 2023-10-26 | -$4.40M 10-Q · filed 2023-10-26 | -$5.30M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-06-30 | -$1.40M 10-Q · filed 2023-07-27 | -$2.20M 10-Q · filed 2023-07-27 | -$3.10M derived: sum of 3 quarters · filed 2024-02-20 | -$4.00M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-03-31 | -$800.00K 10-Q · filed 2023-04-27 | -$1.70M derived: sum of 2 quarters · filed 2024-02-20 | -$2.60M derived: sum of 3 quarters · filed 2024-02-20 | -$3.20M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2021-12-31 | -$900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$1.80M derived: sum of 2 quarters · filed 2024-02-20 | -$2.40M derived: sum of 3 quarters · filed 2024-02-20 | -$3.00M 10-K · filed 2024-02-20 | ||||
| 2021-09-30 | -$900.00K 10-Q · filed 2022-10-27 | $900.00K 10-Q · filed 2021-10-28 | -$1.50M derived: sum of 2 quarters · filed 2022-10-27 | -$2.10M 10-Q · filed 2022-10-27 | $2.10M 10-Q · filed 2021-10-28 | -$14.10M derived: sum of 4 quarters · filed 2023-02-21 | ||
| 2021-06-30 | -$600.00K 10-Q · filed 2022-07-28 | $600.00K 10-Q · filed 2021-07-30 | -$1.20M 10-Q · filed 2022-07-28 | $1.20M 10-Q · filed 2021-07-30 | -$13.20M derived: sum of 3 quarters · filed 2023-02-21 | -$11.30M derived: sum of 4 quarters · filed 2023-02-21 | ||
| 2021-03-31 | -$600.00K 10-Q · filed 2022-04-28 | $600.00K 10-Q · filed 2021-04-30 | -$12.60M derived: sum of 2 quarters · filed 2023-02-21 | -$10.70M derived: sum of 3 quarters · filed 2023-02-21 | -$8.70M derived: sum of 4 quarters · filed 2023-02-21 | |||
| 2020-12-31 | -$12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | -$10.10M derived: sum of 2 quarters · filed 2023-02-21 | -$8.10M derived: sum of 3 quarters · filed 2023-02-21 | -$6.10M 10-K · filed 2023-02-21 | $6.10M 10-K · filed 2021-02-23 | |||
| 2020-09-30 | $1.90M 10-Q · filed 2021-10-28 | $3.90M derived: sum of 2 quarters · filed 2021-10-28 | $5.90M 10-Q · filed 2021-10-28 | -$6.00M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-06-30 | $2.00M 10-Q · filed 2021-07-30 | $3.90M 10-Q · filed 2021-07-30 | -$7.90M derived: sum of 3 quarters · filed 2022-02-22 | -$12.20M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-03-31 | $2.00M 10-Q · filed 2021-04-30 | -$9.90M derived: sum of 2 quarters · filed 2022-02-22 | -$14.20M derived: sum of 3 quarters · filed 2022-02-22 | -$9.70M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2019-12-31 | -$11.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$16.20M derived: sum of 2 quarters · filed 2022-02-22 | -$11.70M derived: sum of 3 quarters · filed 2022-02-22 | -$6.90M 10-K · filed 2022-02-22 | $6.90M 10-K · filed 2021-02-23 | |||
| 2019-09-30 | -$4.30M 10-Q · filed 2020-10-23 | $200.00K derived: sum of 2 quarters · filed 2020-10-23 | $5.00M 10-Q · filed 2020-10-23 | |||||
| 2019-06-30 | $4.50M 10-Q · filed 2020-07-24 | $9.30M 10-Q · filed 2020-07-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |